ARCHIVES

IOM Report: Seek More Comment From Public On Priorities, NIH Told

This article is from The Cancer Letter archive.

Vol. 24 No. 28 | July 17, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

July 29, 2005

Surgeon General plans new report, database, on tobacco.

January 16, 2004

ACCC Members Find Few Answers, Many Problems

February 7, 1975

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

Reinventing NCI: clinical Trials report Calls for Study Section, increased Funding For Cooperative Groups

October 3, 1997